Stocks›Healthcare›TMDX

TMDX

TransMedics Group, Inc.

NasdaqResearch view

Healthcare · Electromedical & Electrotherapeutic Apparatus · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$3.0B

Enterprise Value$2.6B

Income$190.3M

Sales$605.5M

Book/sh$13.64

Cash/sh$14.10

Dividend TTM$0.00

Payout—

Employees—

IPO—

Quick Ratio6.59

Current Ratio7.14

Debt/Eq0.15

EPS (ttm)$4.87

EPS this Y382.2%

EPS past 3/5Y—

Sales past 3/5Y86.4%

EPS Y/Y TTM382.2%

Sales Y/Y TTM37.1%

Shs Outstand34.68M

ROA17.8%

ROE40.2%

ROIC362.4%

Gross Margin59.9%

Oper. Margin17.9%

Profit Margin31.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$31.4M

2021

$93.5M

2022

$241.6M

2023

$441.5M

2024

$605.5M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$31.4M	$93.5M	$241.6M	$441.5M	$605.5M
Gross Profit	$21.2M	$65.3M	$154.1M	$262.1M	$362.8M
Operating Income	$-39.4M	$-31.4M	$-28.7M	$37.5M	$108.6M
Net Income	$-44.2M	$-36.2M	$-25.0M	$35.5M	$190.3M
Diluted EPS	$-1.60	$-1.23	$-0.77	$1.01	$4.87
Operating Cash Flow	$-28.9M	$-45.8M	$-13.0M	$48.8M	$192.8M
Free Cash Flow	$-32.4M	$-57.7M	$-164.9M	$-80.9M	$133.6M